Global equities rose in March on expectations for accelerating global growth following vaccine rollouts, further stimulus measures and ongoing accommodative monetary policy. Developed market equities outperformed…
Global equities rose on optimism that improved vaccine distribution would accelerate 2021 global growth, but was partly offset towards month-end by rising bond yields on fears that more stimulus and supply…
After key bourses achieved intra-month all-time highs, global equities took a breather as the vaccine-led cyclical recovery stumbled on the emergence of more contagious and more virulent COVID-19. Developed market…
The Foord Global Equity Fund performed extraordinarily well in 2020, which was an extraordinary year by any measure. Portfolio manager Ishreth Hassen reviews the fund’s index-beating performance.
Developed market equities again reached new highs on the first COVID-19 vaccine approvals by US, UK and EU regulators and the passage in the US of a $900 billion pandemic relief bill. Despite accelerating COVID-19…
Global equities fell for the second consecutive month after US stimulus delays, slow vaccine development and accelerating COVID-19 infections served to arrest the market’s rally. US equities also fell as US election…
